SCHEMBL19207726

SCHEMBL19207726

CN1C(=O)C(NC(=O)c2ncc(Cc3ccccc3)s2)COc2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 20/20 1.00
NR1I2 O75469 1/20 0.64
CYP2C9 P11712 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19207725 1.00 RIPK1 (1.00) RIPK1NR1I2CYP2C9
SCHEMBL29415766 0.88 RIPK1 (1.00) RIPK1
SCHEMBL19207576 0.88 RIPK1 (1.00) RIPK1
SCHEMBL19207579 0.88 RIPK1 (1.00) RIPK1
SCHEMBL19207810 0.88 RIPK1 (1.00) RIPK1
SCHEMBL19207806 0.88 RIPK1 (1.00) RIPK1
SCHEMBL20904027 0.86 RIPK1 (0.78) RIPK1NR1I2CYP2C9
SCHEMBL17312701 0.85 RIPK1 (0.73) RIPK1NR1I2CYP2C9
SCHEMBL17312704 0.85 RIPK1 (0.73) RIPK1NR1I2CYP2C9
SCHEMBL19866126 0.83 RIPK1 (0.71) RIPK1NR1I2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414239-A2 INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 Denali Therapeutics Inc. (US) 2018-12-19 EP disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed